Yanling Wu

InstitutionFudan University
AddressShanghai
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 16 Covid-19 publications, with a maximum of 4 publications in January 2021
    All Publications
    Bar chart showing 139 publications over 20 distinct years, with a maximum of 16 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Awadasseid A, Yin Q, Wu Y, Zhang W. Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection. Biomed Pharmacother. 2021 Oct; 142:111957. PMID: 34339917.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    2. Zhu X, Yu F, Wu Y, Ying T. Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy. Antib Ther. 2021 Apr; 4(2):89-98. PMID: 34104872.
      Citations:    
    3. Li C, Tian X, Jia X, Wan J, Lu L, Jiang S, Lan F, Lu Y, Wu Y, Ying T. The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2. Signal Transduct Target Ther. 2021 03 23; 6(1):132. PMID: 33758169.
      Citations: 11     Translation:HumansCells
    4. Awadasseid A, Wu Y, Tanaka Y, Zhang W. Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines. Biomed Pharmacother. 2021 May; 137:111330. PMID: 33550043.
      Citations: 5     Fields:    Translation:Humans
    5. Zhou Y, Liu Z, Li S, Xu W, Zhang Q, Silva IT, Li C, Wu Y, Jiang Q, Liu Z, Wang Q, Guo Y, Wu J, Gu C, Cai X, Qu D, Mayer CT, Wang X, Jiang S, Ying T, Yuan Z, Xie Y, Wen Y, Lu L, Wang Q. Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD. Cell Rep. 2021 02 02; 34(5):108699. PMID: 33485405.
      Citations: 25     Fields:    Translation:HumansCells
    6. Awadasseid A, Wu Y, Tanaka Y, Zhang W. Current advances in the development of SARS-CoV-2 vaccines. Int J Biol Sci. 2021; 17(1):8-19. PMID: 33390829.
      Citations: 17     Fields:    Translation:Humans
    7. Awadasseid A, Wu Y, Tanaka Y, Zhang W. SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations. Int J Biol Sci. 2021; 17(1):97-106. PMID: 33390836.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    8. Liu Z, Xu W, Xia S, Gu C, Wang X, Wang Q, Zhou J, Wu Y, Cai X, Qu D, Ying T, Xie Y, Lu L, Yuan Z, Jiang S. RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response. Signal Transduct Target Ther. 2020 11 27; 5(1):282. PMID: 33247109.
      Citations: 34     Translation:HumansAnimalsCellsPHPublic Health
    9. Wu X, Chen J, Yun D, Yuan M, Liu Z, Yan P, Sim DA, Zhu Y, Chen C, Hu W, Wu Z, Lin H, Wang Y, Wu Y, Chen M, Zhang C, Zheng Y, Liu X, Zhong X, Diao H, Wei Ting DS, Gunasekeran DV, Li Y, Zhang J, Cai Y, Lao Z, Liu Y, Wong TY, Lin X, Lin X, Lin H. Effectiveness of an Ophthalmic Hospital-Based Virtual Service during the COVID-19 Pandemic. Ophthalmology. 2021 06; 128(6):942-945. PMID: 33069751.
      Citations: 2     Fields:    Translation:Humans
    10. Li Y, Lai DY, Zhang HN, Jiang HW, Tian X, Ma ML, Qi H, Meng QF, Guo SJ, Wu Y, Wang W, Yang X, Shi DW, Dai JB, Ying T, Zhou J, Tao SC. Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients. Cell Mol Immunol. 2020 10; 17(10):1095-1097. PMID: 32895485.
      Citations: 47     Fields:    Translation:HumansCellsPHPublic Health
    11. Wan J, Xing S, Ding L, Wang Y, Gu C, Wu Y, Rong B, Li C, Wang S, Chen K, He C, Zhu D, Yuan S, Qiu C, Zhao C, Nie L, Gao Z, Jiao J, Zhang X, Wang X, Ying T, Wang H, Xie Y, Lu Y, Xu J, Lan F. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection. Cell Rep. 2020 07 21; 32(3):107918. PMID: 32668215.
      Citations: 59     Fields:    Translation:HumansCellsPHPublic Health
    12. Wu Y, Li C, Xia S, Tian X, Kong Y, Wang Z, Gu C, Zhang R, Tu C, Xie Y, Yang Z, Lu L, Jiang S, Ying T. Identification of Human Single-Domain Antibodies against SARS-CoV-2. Cell Host Microbe. 2020 06 10; 27(6):891-898.e5. PMID: 32413276.
      Citations: 89     Fields:    Translation:HumansCells
    13. Shen LW, Qian MQ, Yu K, Narva S, Yu F, Wu YL, Zhang W. Inhibition of Influenza A virus propagation by benzoselenoxanthenes stabilizing TMPRSS2 Gene G-quadruplex and hence down-regulating TMPRSS2 expression. Sci Rep. 2020 05 06; 10(1):7635. PMID: 32376987.
      Citations: 11     Fields:    Translation:HumansCells
    14. Awadasseid A, Wu Y, Tanaka Y, Zhang W. Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China. Int J Biol Sci. 2020; 16(11):1846-1860. PMID: 32398954.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    15. Tian X, Li C, Huang A, Xia S, Lu S, Shi Z, Lu L, Jiang S, Yang Z, Wu Y, Ying T. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect. 2020; 9(1):382-385. PMID: 32065055.
      Citations: 534     Fields:    Translation:HumansCells
    16. Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y, Ying T, Liu S, Shi Z, Jiang S, Lu L. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol Immunol. 2020 07; 17(7):765-767. PMID: 32047258.
      Citations: 201     Fields:    Translation:HumansCellsPHPublic Health
    17. Wang L, Xu J, Kong Y, Liang R, Li W, Li J, Lu J, Dimitrov DS, Yu F, Wu Y, Ying T. Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV. Antibodies (Basel). 2019 Nov 04; 8(4). PMID: 31690009.
      Citations: 5     
    18. Shen LW, Mao HJ, Wu YL, Tanaka Y, Zhang W. TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections. Biochimie. 2017 Nov; 142:1-10. PMID: 28778717.
      Citations: 103     Fields:    Translation:HumansAnimals
    Wu's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (311)
    Explore
    _
    Co-Authors (140)
    Explore
    _
    Similar People (60)
    Explore
    _